Shi Lou
Fondateur chez Hope Medicine (Nanjing) Co., Ltd.
Provenance du réseau au premier degré de Shi Lou
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Hope Medicine (Nanjing) Co., Ltd.
 Hope Medicine (Nanjing) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Hope Medicine (HK) Ltd., Hope Medicine (Nanjing) Co., Ltd. is a pharmaceutical company based in Shanghai, China. The Chinese company manufactures pharmaceutical products. The company was founded in 2018 by Shi Lou, Rui Ping Xiao. Henri Nico Doods has been the CEO of the company since 2020.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Shi Lou via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Corporate Officer/Principal | |
| University of Amsterdam | College/University | Doctorate Degree | |
| The Institute of Molecular Medicine | Founder | ||
| University of Maryland School of Medicine | College/University | Graduate Degree | |
| Tongji Medical College of Huazhong University of Sci & Tech | College/University | Graduate Degree | |
TransThera Sciences (Nanjing), Inc.
 TransThera Sciences (Nanjing), Inc. BiotechnologyHealth Technology TransThera Sciences (Nanjing), Inc. engages in the research and development of clinical biopharmaceutics. It focuses on the discovery and development of small molecule innovative therapies for tumors, inflammations, and cardiovascular diseases. The company was founded by Frank Wu on April 15, 2014 and is headquartered in Nanjing, China. | Biotechnology | Director/Board Member | |
| International Society For Heart Research | Corporate Officer/Principal | ||
Vivere Lifesciences Acquisition Corp.
 Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Financial Conglomerates | Corporate Officer/Principal |
Statistiques
Internationale
| Chine | 4 |
| Etats-Unis | 4 |
| Pays-Bas | 2 |
| Hong Kong | 2 |
Sectorielle
| Consumer Services | 5 |
| Health Technology | 2 |
| Finance | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
| Director/Board Member | 2 |
| Founder | 2 |
| Graduate Degree | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| Rui Ping Xiao | 7 |
| Henri Nico Doods | 3 |
